Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Genes, erbB-1"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Immunohistochemical Classification of Primary and Secondary Glioblastomas
Kyu Sang Lee, Gheeyoung Choe, Kyung Han Nam, An Na Seo, Sumi Yun, Kyung Ju Kim, Hwa Jin Cho, Sung Hye Park
Korean J Pathol. 2013;47(6):541-548.   Published online December 24, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.6.541
  • 7,000 View
  • 51 Download
  • 16 Crossref
AbstractAbstract PDF
Background

Glioblastomas may develop de novo (primary glioblastomas, P-GBLs) or through progression from lower-grade astrocytomas (secondary glioblastomas, S-GBLs). The aim of this study was to compare the immunohistochemical classification of glioblastomas with clinically determined P-GBLs and S-GBLs to identify the best combination of antibodies for immunohistochemical classification.

Methods

We evaluated the immunohistochemical expression of epidermal growth factor receptor (EGFR), p53, and isocitrate dehydrogenase 1 (IDH-1) in 150 glioblastoma cases.

Results

According to clinical history, the glioblastomas analyzed in this study consisted of 146 P-GBLs and 4 S-GBLs. Immunohistochemical expression of EGFR, p53, and IDH-1 was observed in 62.6%, 49.3%, and 11.1%, respectively. Immunohistochemical profiles of EGFR(+)/p53(-), IDH-1(-)/EGFR(+)/p53(-), and EGFR(-)/p53(+) were noted in 41.3%, 40.2%, and 28.7%, respectively. Expression of IDH-1 and EGFR(-)/p53(+) was positively correlated with young age. The typical immunohistochemical features of S-GBLs comprised IDH-1(+)/EGFR(-)/p53(+), and were noted in 3.6% of clinically P-GBLs. The combination of IDH-1(-) or EGFR(+) was the best set of immunohistochemical stains for identifying P-GBLs, whereas the combination of IDH-1(+) and EGFR(-) was best for identifying S-GBLs.

Conclusions

We recommend a combination of IDH-1 and EGFR for immunohistochemical classification of glioblastomas. We expect our results to be useful for determining treatment strategies for glioblastoma patients.

Citations

Citations to this article as recorded by  
  • Cutaneous Melanoma and Glioblastoma Multiforme Association—Case Presentation and Literature Review
    Olguța Anca Orzan, Călin Giurcăneanu, Bogdan Dima, Monica Beatrice Dima, Ana Ion, Beatrice Bălăceanu, Cornelia Nițipir, Irina Tudose, Cătălina Andreea Nicolae, Alexandra Maria Dorobanțu
    Diagnostics.2023; 13(6): 1046.     CrossRef
  • Primary Extra-axial Glioblastoma: Case Report and Literature Review
    Baraa Dabboucy, Philippe Younes, Abdallah Rahbani, Elie Fahed, Gérard Abadjian
    Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery.2021; 40(04): e368.     CrossRef
  • TERT Promoter Mutation in Adult Glioblastomas: It's Correlation with Other Relevant Molecular Markers
    Mukesh Barange, Sridhar Epari, Mamta Gurav, Omshree Shetty, Ayushi Sahay, Prakash Shetty, Jayantsastri Goda, Aliasagar Moyiadi, Tejpal Gupta, Rakesh Jalali
    Neurology India.2021; 69(1): 126.     CrossRef
  • Immunohistochemical characterisation and histopathology of astrocytic neoplasms at a tertiary Nigerian hospital
    Michael Nweke, Gabriel Ogun, Amos Adeleye, Clement A. Okolo, Adekunle Adesina
    International Journal of Clinical Practice.2021;[Epub]     CrossRef
  • Cytotoxic Effects of Blue Scorpion Venom (Rhopalurus junceus) in a Glioblastoma Cell Line Model
    Laura A. Lozano-Trujillo, Diana K. Garzón-Perdomo, Andrea C.R. Vargas, Lina M. de los Reyes, Marco F. Avila-Rodriguez, Olivia T.G. Gay, Liliana F. Turner
    Current Pharmaceutical Biotechnology.2021; 22(5): 636.     CrossRef
  • Molecular Subgroups of Glioblastoma– an Assessment by Immunohistochemical Markers
    Ádám Nagy, Ferenc Garzuly, Gergely Padányi, Iván Szűcs, Ádám Feldmann, Balázs Murnyák, Tibor Hortobágyi, Bernadette Kálmán
    Pathology & Oncology Research.2019; 25(1): 21.     CrossRef
  • Proteomic Advances in Glial Tumors through Mass Spectrometry Approaches
    Radu Pirlog, Sergiu Susman, Cristina Adela Iuga, Stefan Ioan Florian
    Medicina.2019; 55(8): 412.     CrossRef
  • Isocitrate dehydrogenase 1 mutant glioblastomas demonstrate a decreased rate of pseudoprogression: a multi-institutional experience
    Homan Mohammadi, Kevin Shiue, G Daniel Grass, Vivek Verma, Kay Engellandt, Dirk Daubner, Gabriele Schackert, Mercia J Gondim, Dibson Gondim, Alexander O Vortmeyer, Aaron P Kamer, William Jin, Timothy J Robinson, Gordon Watson, Hsiang-Hsuan M Yu, Tim Laute
    Neuro-Oncology Practice.2019;[Epub]     CrossRef
  • Calvarium mass as the first presentation of glioblastoma multiforme: A very rare manifestation of high-grade glioma
    S. Taghipour Zahir, M. Mortaz, M. Baghi Yazdi, N. Sefidrokh Sharahjin, M. Shabani
    Neurochirurgie.2018; 64(1): 76.     CrossRef
  • Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study
    Ewa Izycka-Swieszewska, Ewa Bien, Joanna Stefanowicz, Edyta Szurowska, Ewa Szutowicz-Zielinska, Magdalena Koczkowska, Dawid Sigorski, Wojciech Kloc, Wojciech Rogowski, Elzbieta Adamkiewicz-Drozynska
    BioMed Research International.2018; 2018: 1.     CrossRef
  • Prognostic significance of mutant IDH1, CD133, and β-catenin immunohistochemical expression in glioblastoma multiforme
    Azza Abdel-Aziz, Mie A. Mohamed, Dina Abdallah, Fatma M.F. Akl, Ghada E. Eladawy, Ahmed N. Taha, Hossam Shata
    Egyptian Journal of Pathology.2018; 38(1): 27.     CrossRef
  • On glioblastoma and the search for a cure: where do we stand?
    John Bianco, Chiara Bastiancich, Aleksander Jankovski, Anne des Rieux, Véronique Préat, Fabienne Danhier
    Cellular and Molecular Life Sciences.2017; 74(13): 2451.     CrossRef
  • Development of Glioblastoma after Treatment of Brain Abscess
    Hiroaki Matsumoto, Hiroaki Minami, Shogo Tominaga, Yasuhisa Yoshida
    World Neurosurgery.2016; 88: 686.e19.     CrossRef
  • Clinical, immunohistochemical, and molecular genetic prognostic factors in adult patients with glioblastoma
    N. V. Lobanova, L. V. Shishkina, M. V. Ryzhova, G. L. Kobyakov, R. V. Sycheva, S. A. Burov, A. V. Lukyanov, Zh. R. Omarova
    Arkhiv patologii.2016; 78(4): 10.     CrossRef
  • Concordance analysis and diagnostic test accuracy review of IDH1 immunohistochemistry in glioblastoma
    Jung-Soo Pyo, Nae Yu Kim, Roy Hyun Jai Kim, Guhyun Kang
    Brain Tumor Pathology.2016; 33(4): 248.     CrossRef
  • Methyl Guanine Methyl Transferase Methylation Status and Epidermal Growth Factor Receptor expression in a cohort of Egyptian glioblastoma patients
    Soheir M. Hamam, Bassma M. El Sabaa, Iman M. Talaat, Rasha A. Nassra, Doaa A. Abdelmonsif
    Egyptian Journal of Pathology.2016; 36(2): 282.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine